IPP Bureau
Sankara Eye Hospital hosts ‘CSSD 360’ workshop on sterilisation and patient safety
By IPP Bureau - May 04, 2026
Workshop focused on strengthening sterile processing standards, infection prevention, and CSSD best practices in healthcare settings
ten23 health successfully tests West Synchrony S1 PFS system on fill-finish lines
By IPP Bureau - May 04, 2026
Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners
HOSMAC enables first phase of 1,200-bed Tapanbhai Patel Memorial Hospital in Shirpur
By IPP Bureau - May 04, 2026
Hospital project inaugurated by Devendra Fadnavis aims to strengthen healthcare access across North Maharashtra and nearby regions
Wockhardt reports FY26 net profit of Rs 317 crore, Board approves fundraising plan
By IPP Bureau - May 04, 2026
Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance
FDA advisory panel backs AstraZeneca prostate cancer combo in decisive vote
By IPP Bureau - May 04, 2026
The Committee backed the combination based on results from the CAPItello-281 Phase III trial, marking a key milestone in the regulatory pathway for AstraZeneca’s targeted therapy strategy in prostate cancer
Allergan Aesthetics ties referrals to skin cancer awareness month with $100,000 donation drive
By IPP Bureau - May 04, 2026
The initiative pairs consumer engagement with a public health message about prevention and early detection
Bristol Myers Squibb begins 2026 with growth momentum
By IPP Bureau - May 04, 2026
The company’s Growth Portfolio delivered $6.2 billion in revenue
Lilly posts explosive Q1 2026 results
By IPP Bureau - May 04, 2026
Lifts full-year outlook as obesity drug boom accelerates
FDA advisory panel narrowly withholds support for AstraZeneca’s combo in breast cancer
By IPP Bureau - May 04, 2026
The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 3 to 6 against recommending camizestrant in combination with a CDK4/6 inhibitor
Sanofi India appoints Rahul Bhatnagar as Chairman of Board of Directors
By IPP Bureau - May 03, 2026
Rahul Bhatnagar succeeds Aditya Narayan, who completed a decade-long distinguished tenure
FDA grants breakthrough status to Laguna's mRNA blood test for schizophrenia diagnosis
By IPP Bureau - May 02, 2026
The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay
FDA renews IQOS “reduced-risk” status backing PMI’s smoke-free strategy in regulatory win
By IPP Bureau - May 02, 2026
The renewal covers two versions of the IQOS device and three HEETS tobacco variants
Bayer pushes stroke prevention drug forward in China as regulators accept key filing
By IPP Bureau - May 02, 2026
Stroke is the second-leading cause of death and the third-leading cause of disability worldwide
IMCD posts steady Q1 2026 performance with €130 million EBITA amid global uncertainty
By IPP Bureau - May 02, 2026
The company posted revenue of €1,267 million, up 6% on a constant currency basis
Gilead completes $7.8B Arcellx acquisition & takes full control of Myeloma CAR-T candidate
By IPP Bureau - May 02, 2026
Under the terms, Arcellx shareholders received $115 per share in cash plus a non-transferable contingent value right
